nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases
|
Arencibia, José M. |
|
2013 |
1834 |
7 |
p. 1302-1321 20 p. |
artikel |
2 |
Beyond control of protein translation: What we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR)
|
Malik, Anna R. |
|
2013 |
1834 |
7 |
p. 1434-1448 15 p. |
artikel |
3 |
Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: Applications to protein kinase CK2
|
Gyenis, Laszlo |
|
2013 |
1834 |
7 |
p. 1352-1358 7 p. |
artikel |
4 |
Development of novel molecular probes of the Rio1 atypical protein kinase
|
Mielecki, Marcin |
|
2013 |
1834 |
7 |
p. 1292-1301 10 p. |
artikel |
5 |
Editorial Board
|
|
|
2013 |
1834 |
7 |
p. i- 1 p. |
artikel |
6 |
Evolutionary variation and adaptation in a conserved protein kinase allosteric network: Implications for inhibitor design
|
Oruganty, Krishnadev |
|
2013 |
1834 |
7 |
p. 1322-1329 8 p. |
artikel |
7 |
Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases
|
Cozza, Giorgio |
|
2013 |
1834 |
7 |
p. 1402-1409 8 p. |
artikel |
8 |
Fluorescent biosensors — Probing protein kinase function in cancer and drug discovery
|
Morris, May C. |
|
2013 |
1834 |
7 |
p. 1387-1395 9 p. |
artikel |
9 |
GSK-3 inhibition: Achieving moderate efficacy with high selectivity
|
Avrahami, Limor |
|
2013 |
1834 |
7 |
p. 1410-1414 5 p. |
artikel |
10 |
Halogen bonding at the ATP binding site of protein kinases: Preferred geometry and topology of ligand binding
|
Poznański, Jarosław |
|
2013 |
1834 |
7 |
p. 1381-1386 6 p. |
artikel |
11 |
Inhibitors of protein kinases
|
Shugar, David |
|
2013 |
1834 |
7 |
p. 1269-1270 2 p. |
artikel |
12 |
Intersection of selenoproteins and kinase signalling
|
Lenart, Anna |
|
2013 |
1834 |
7 |
p. 1279-1284 6 p. |
artikel |
13 |
Localised interventions in cellular processes
|
Peel, Nick |
|
2013 |
1834 |
7 |
p. 1364-1370 7 p. |
artikel |
14 |
Mechanisms of resistance to BCR-ABL and other kinase inhibitors
|
Lamontanara, Allan Joaquim |
|
2013 |
1834 |
7 |
p. 1449-1459 11 p. |
artikel |
15 |
Nima- and Aurora-related kinases of malaria parasites
|
Carvalho, Teresa Gil |
|
2013 |
1834 |
7 |
p. 1336-1345 10 p. |
artikel |
16 |
Overcoming resistance to rapalogs in gliomas by combinatory therapies
|
Grzmil, Michal |
|
2013 |
1834 |
7 |
p. 1371-1380 10 p. |
artikel |
17 |
PKA: Lessons learned after twenty years
|
Taylor, Susan S. |
|
2013 |
1834 |
7 |
p. 1271-1278 8 p. |
artikel |
18 |
Probes of the mitochondrial cAMP-dependent protein kinase
|
Shell, Jennifer R. |
|
2013 |
1834 |
7 |
p. 1359-1363 5 p. |
artikel |
19 |
Quantitative NMR analysis of Erk activity and inhibition by U0126 in a panel of patient-derived colorectal cancer cell lines
|
Rose, Honor May |
|
2013 |
1834 |
7 |
p. 1396-1401 6 p. |
artikel |
20 |
Responsive microsecond-lifetime photoluminescent probes for analysis of protein kinases and their inhibitors
|
Kasari, Marje |
|
2013 |
1834 |
7 |
p. 1330-1335 6 p. |
artikel |
21 |
The switch helix: A putative combinatorial relay for interprotomer communication in cGMP-dependent protein kinase
|
Moon, Thomas M. |
|
2013 |
1834 |
7 |
p. 1346-1351 6 p. |
artikel |
22 |
The unusual mechanism of inhibition of the p90 ribosomal S6 kinase (RSK) by flavonol rhamnosides
|
Utepbergenov, Darkhan |
|
2013 |
1834 |
7 |
p. 1285-1291 7 p. |
artikel |
23 |
Transcription regulators controlled by interaction with enzyme IIB components of the phosphoenolpyruvate:sugar phosphotransferase system
|
Joyet, Philippe |
|
2013 |
1834 |
7 |
p. 1415-1424 10 p. |
artikel |
24 |
What general conclusions can we draw from kinase profiling data sets?
|
Sutherland, Jeffrey J. |
|
2013 |
1834 |
7 |
p. 1425-1433 9 p. |
artikel |